Radboudumc and Johnson & Johnson Innovative Medicine are working together on research into the early detection and treatment of lung cancer. This collaboration is part of the European Innovative Health Initiative (IHI) project IMAGIO. The aim of this project is to combine biopsy taking, detection, diagnosis and treatment start-up in a surgical procedure, already at an early stage of the disease process.
Early detection and treatment of lung cancer
Oncology
- Duration
- 2023 until 2027
- Project member(s)
- Roel Verhoeven , Tim Govers , Prof. H.F.M. van der Heijden (Erik) , Colin Jacobs , Erik Aarntzen , Francesco Ciompi
- Project type
- Research
- Organisation
- Radboudumc
Funding
Partners
Radboudumc is collaborating with the University of Twente, the University in Tübingen, the Free University Amsterdam, ETH Zurich, Philips, Flash Pathology, Janssen Pharmaceutica, Pfizer, ImaginAb, Lung Cancer Netherlands and the European Cancer Patient Coalition.
